期刊文献+

PD-1核心启动子的获得及活性鉴定

PD-1 Core Promoter Acquired and Identification
下载PDF
导出
摘要 目的:构建PD-1(programmed death receptor 1)全长启动子及不同截短体的报告基因,并对其转录活性进行检测。方法:通过PCR及双酶切方法,从人全血基因组DNA中获得PD-1基因编码序列,包含不同长度碱基的PD-1启动子序列,分别克隆到报告基因pGL3-Basic载体上,构建8个不同长度PD-1启动子的报告基因;用脂质体转染法将8个报告基因分别转染至Jurkat细胞系;采用双萤光素酶报告基因系统评估PD-1启动子的活性。结果:经PCR方法扩增出大小分别为1650、1450、1250、1128、874、674、474和274 bp的不同长度的PD-1启动子序列,测序正确(与GenBank报道一致),酶切鉴定正确;瞬时转染Jurkat细胞系后经报告基因检测,8个启动子均具有转录活性。结论:构建了PD-1启动子的报告基因,并证实均有转录活性,且以pGL3-1128活性最高,为PD-1的核心启动子,为进一步研究PD-1的转录调控奠定了实验基础。 Objective:To construct the luciferase reporter gene vectors with the whole promoter gene region and different truncated body of PD-1(programmed death receptor 1) and detect the transcriptional activity.Methods:Acquired the PD-1 gene sequences with different length of the promoters from human whole blood genome by PCR and dual-restriction.Subcloned them into luciferase reporter gene vector pGL3-Basic respectively and constructed 8 reporter gene with different length of promoters.Then the recombinant constructs were transfected into Jurkat cells.The promoters activity were evaluated by dual-luciferase reporter assay.Results:The promoter sequence of PD-1 with different length(1650,1450,1250,1128,874,674,474,274 bp) have been amplified by PCR,the sequences were all right(consistent with the sequence showed on GenBank),and the identification of restriction were right.The 8 promoters all were transcriptional activated after transiently transfected into Jurkat cells.Conclusion:The luciferase reporter gene vectors with PD-1 promoter have been constructed successfully and testi-fied to be activity,and pGL3-1128 had the highest activity.All the results laid the experimental foundation for further study on the transcriptional regulation of PD-1.
出处 《生物技术通讯》 CAS 2010年第3期319-322,共4页 Letters in Biotechnology
基金 国家自然科学基金(30972672 30801002)
关键词 PD-1 核心启动子 双萤光素酶报告基因 转录调控 PD-1 core promoter luciferase reporter gene transcriptional regulation
  • 相关文献

参考文献10

二级参考文献69

  • 1Pearlman BL. Hepatitis C treatment update. Am. J. Med, 2004, 117 (5) : 344-352
  • 2Farci P. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science, 2000, 288 (5464) : 339-344
  • 3Post JJ. Clearance of hepatitis C viremia associated with eellular immunity in the absence of seroeonversion in the hepatitis C incidence and transmission in prisons study cohort. J. Infect. Dis, 2004, 189 (10) : 1846- 1855
  • 4Nouri-Aria KT, Sallie R, Mizokami M, et al. lntrahepatie expression of hepatitis C virus antigens in chronie liver disease. J. Pathol, 1995, 175 ( 1 ) : 77-83
  • 5Thimme R. Determinants of viral clearance and persistence during acute hepalilis C virus infection. J. Exp. Med, 2001 , 194 (10) : 1395-1406
  • 6Thimme. R. Viral and immunological determinants of hepaliiis C virus clearance, persistence, and disease: Proc. Natl Acad. Sci. USA, 2002, 99 (24) : 15661-15668
  • 7McGuinness PH, Painter D, Davies S, et al. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18 ) in chronic hepatitis C infection. Gut, 2000, 46 (2): 260-269
  • 8Grakoui A, Shoukry NH, Woolard DJ, et al. HCV persistence and immune evasion in the absence of memory T cell help. Science, 2003, 302 (5645) : 659-662
  • 9Bassett SE, Guerra B, Brasky K, et al. Protective immune response to hepatitis C virus in ehimpanzees reehallenged following clearance of primary infection. Hepatology, 2001, 33 (6) : 1479-1487
  • 10Takaki A, Wiese M, Maertens, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nature Med, 2000, 6 ( 5 ) : 578-582

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部